April 28, 2025. More for You. 90-day clock expires on President Trump’s order for Lumbee ...

Step into Middle-earth with this incredible Lord of the Rings inspired door build! From detailed carvings to fantasy-themed ...

2024's Deadpool and Wolverine was a huge blockbuster built on the team up of the two title characters. And though they wound up leading a group of outcasts in the Void, that might be about as ...

When Deadpool & Wolverine made over a billion dollars at the box office last year, some kind of continuation for Ryan Reynolds as the MCU’s Deadpool was all but guaranteed. The question remained ...

Despite Madame Web being a notorious flop, the Sony Marvel movie beat Deadpool and Wolverine on streaming. Per a report from ComicBook.com using Nielsen data, Madame Web brought in 16 million ...

Ryan Reynolds has recently dished out some new info regarding Deadpool’s next entry in the Marvel Cinematic Universe, and it sounds a bit smaller scale than we expected, but in a good way. Reynolds ...

Believe it or not, this iconic film, Deadpool, almost never got made. Yep, the studio wasn’t too thrilled about taking a risk on a snarky, foul-mouthed antihero in a red suit who breaks the ...

As well as how they decide the Gems of the Month, with Dynamite Entertainment's The Nightmare Before Christmas: Long Live the Pumpkin Queen OGN, Space Ghost #1 and Vampirella: Armageddon #1.

Deadpool & Wolverine writers Rhett Reese and Paul Wernick are penning the screenplay, with Wicked and G.I. Joe: Retaliation helmer Jon M. Chu set to direct. That's some heavyweight talent ...

Joining Sweeney and Chu on the film are screenwriters Rhett Reese and Paul Wernick, known for Deadpool & Wolverine. At the time of writing, it has not been decided whether Sweeney will play Mio or ...

From developer Hazelight Studios and publisher Electronic Arts, “Split Fiction” blends fantasy and science fiction, following a pair of authors, Mio and Zoe, who become trapped in the worlds ...

Erasca, Inc. focuses on developing novel targeted therapies for solid tumors, particularly through the RAS/MAP kinase pathway, with a promising yet early-stage pipeline. The company’s lead ...